One last effort. Are high out-of-pocket payments at the end of life a fatality?
{{output}}
Only few studies outside of the US have addressed the issue of out-of-pocket payments (OOP) at the end of life because of a lack of data. We use an exclusive dataset from a major French health insurance company (MGEN), including claim data, both mandatory and ... ...
